$PPHM, expecting to hear good news and higher earnings after the market close

Q4 2013 Peregrine Pharmaceuticals Earnings Release-After Market Close

http://biz.yahoo.com/research/earncal/20130711.html?t=pphm

Peregrine Pharmaceuticals (PPHM) reports after the closing bell. The stock rose 5% yesterday. Peregrine is expected to post a loss of 6-cents a share. That would be an improvement from losses of 10-cents a share a year ago. Revenue it likely to be up more than 50%, but to only $3.5 million. Peregrine concentrates on antibody-based treatments for cancer, hepatitis-C and other viral infections. It currently has a market cap of about $200 million. Shares are up 96% over the past year. But the stock dropped 10% in the past month because company has abandoned tests of a cancer treatment.

http://finance.yahoo.com/blogs/hot-stock-minu...28797.html